Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Similar Journals
Journal Cover
Nature Reviews Drug Discovery
Journal Prestige (SJR): 10.106
Citation Impact (citeScore): 10
Number of Followers: 410  
 
  Full-text available via subscription Subscription journal
ISSN (Print) 1474-1776 - ISSN (Online) 1474-1784
Published by NPG Homepage  [138 journals]
  • Impact of COVID-19 on oncology clinical trials
    • Nature Reviews Drug Discovery, Published online: 18 May 2020; doi:10.1038/d41573-020-00093-1

      Impact of COVID-19 on oncology clinical trialsNature Reviews Drug Discovery, Published online: 2020-05-18; doi:10.1038/d41573-020-00093-12020-05-18
      DOI: 10.1038/d41573-020-00093-1
       
  • Jennifer Doudna
    • Nature Reviews Drug Discovery, Published online: 15 May 2020; doi:10.1038/d41573-020-00095-z

      CRISPR–Cas gene editors are now both moving into the clinic and being embraced as a means to find and validate drug targets. But for Jennifer Doudna, who helped pioneer this promise with her work at UC Berkeley, the full potential of these tools will only be unleashed when they can be used at scale. To this end, Doudna and colleagues partnered last year with GlaxoSmithKline to launch the Laboratory for Genomic Research (LGR), a US$67 million effort aimed at industrializing the CRISPR–Cas workflow for the detailed exploration of human genetics. One year on, she spoke with Asher Mullard about her hopes for CRISPR–Cas editors as drug discovery tools, the types of projects the LGR is working on and the challenges they face.Nature Reviews Drug Discovery, Published online: 2020-05-15; doi:10.1038/d41573-020-00095-z2020-05-15
      DOI: 10.1038/d41573-020-00095-z
       
  • Gene-editing pipeline takes off
    • Nature Reviews Drug Discovery, Published online: 15 May 2020; doi:10.1038/d41573-020-00096-y

      Clinical trials of genome-editing agents — including CRISPR–Cas9 editors, zinc finger nucleases and TALENs — are pushing ex vivo, immuno-oncology and in vivo treatment frontiers.Nature Reviews Drug Discovery, Published online: 2020-05-15; doi:10.1038/d41573-020-00096-y2020-05-15
      DOI: 10.1038/d41573-020-00096-y
       
  • Remote digital monitoring in clinical trials in the time of COVID-19
    • Nature Reviews Drug Discovery, Published online: 14 May 2020; doi:10.1038/d41573-020-00094-0

      Remote digital monitoring in clinical trials in the time of COVID-19 Nature Reviews Drug Discovery, Published online: 2020-05-14; doi:10.1038/d41573-020-00094-02020-05-14
      DOI: 10.1038/d41573-020-00094-0
       
  • KNa1.1 channels as a target for treating early-onset epilepsy
    • Nature Reviews Drug Discovery, Published online: 13 May 2020; doi:10.1038/d41573-020-00092-2

      KNa1.1 channels as a target for treating early-onset epilepsyNature Reviews Drug Discovery, Published online: 2020-05-13; doi:10.1038/d41573-020-00092-22020-05-13
      DOI: 10.1038/d41573-020-00092-2
       
  • Digital technologies for medicines: shaping a framework for success
    • Nature Reviews Drug Discovery, Published online: 12 May 2020; doi:10.1038/d41573-020-00080-6

      Regulatory agencies can provide advice to support developers of digital technologies for medicines use, but what are the best strategies to maximise the chance of a successful regulatory interaction? Here, EMA and industry representatives comment on the experience so far.Nature Reviews Drug Discovery, Published online: 2020-05-12; doi:10.1038/d41573-020-00080-62020-05-12
      DOI: 10.1038/d41573-020-00080-6
       
  • Hints of hope with remdesivir
    • Nature Reviews Drug Discovery, Published online: 11 May 2020; doi:10.1038/d41573-020-00088-y

      Hints of hope with remdesivirNature Reviews Drug Discovery, Published online: 2020-05-11; doi:10.1038/d41573-020-00088-y2020-05-11
      DOI: 10.1038/d41573-020-00088-y
       
  • Parkinson disease setback
    • Nature Reviews Drug Discovery, Published online: 11 May 2020; doi:10.1038/d41573-020-00090-4

      Parkinson disease setbackNature Reviews Drug Discovery, Published online: 2020-05-11; doi:10.1038/d41573-020-00090-42020-05-11
      DOI: 10.1038/d41573-020-00090-4
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 34.231.21.83
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-